Cargando…
Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator
Tissue plasminogen activator (tPA) thrombolysis continues to be the gold standard therapy for ischemic stroke. Due to the time-limited treatment window, within 4.5 h of stroke onset, and a variety of potentially deadly complications related to delayed administration, particularly hemorrhagic transfo...
Autores principales: | Knecht, Talia, Borlongan, Cesar, dela Peña, Ike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187940/ https://www.ncbi.nlm.nih.gov/pubmed/30450415 http://dx.doi.org/10.4103/bc.bc_21_18 |
Ejemplares similares
-
Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment
por: Knecht, Talia, et al.
Publicado: (2017) -
Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke
por: dela Peña, Ike C., et al.
Publicado: (2018) -
Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need
por: Peña, Ike dela, et al.
Publicado: (2017) -
Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis
por: dela Peña, Ike C, et al.
Publicado: (2015) -
Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke
por: Tajiri, Naoki, et al.
Publicado: (2014)